4572-80-9 Usage
Uses
Used in Pharmaceutical Research and Development:
3-(1,4-DIOXO-3,4-DIHYDROPHTHALAZIN-2(1H)-YL)PROPANOIC ACID is utilized as a chemical entity in the research and development of pharmaceutical drugs due to its potential biological and pharmacological activities. It may contribute to the discovery of new therapeutic agents or the enhancement of existing ones.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 3-(1,4-DIOXO-3,4-DIHYDROPHTHALAZIN-2(1H)-YL)PROPANOIC ACID is used as a building block or a scaffold for the synthesis of new compounds with potential medicinal properties. Its unique structure allows for modifications that can lead to the development of drugs with improved efficacy and selectivity.
Used in Drug Design:
3-(1,4-DIOXO-3,4-DIHYDROPHTHALAZIN-2(1H)-YL)PROPANOIC ACID is employed in drug design as a template for creating novel molecules with specific therapeutic targets. Its structural features can be exploited to design drugs that interact with biological macromolecules, such as proteins or enzymes, to achieve desired pharmacological effects.
Used in Biochemical Studies:
In biochemical research, 3-(1,4-DIOXO-3,4-DIHYDROPHTHALAZIN-2(1H)-YL)PROPANOIC ACID may be used as a probe or a tool to study the mechanisms of biological processes. Its interaction with various biomolecules can provide insights into the molecular basis of diseases and potential therapeutic interventions.
Check Digit Verification of cas no
The CAS Registry Mumber 4572-80-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,7 and 2 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4572-80:
(6*4)+(5*5)+(4*7)+(3*2)+(2*8)+(1*0)=99
99 % 10 = 9
So 4572-80-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H10N2O4/c14-9(15)5-6-13-11(17)8-4-2-1-3-7(8)10(16)12-13/h1-4H,5-6H2,(H,12,16)(H,14,15)
4572-80-9Relevant articles and documents
2,3-dihydrophthalazine-1,4-diones
-
, (2008/06/13)
A compound having the structural formula STR1 wherein R1 is hydrogen, C1 -C6 alkyl, C2 -C6 carbalkoxyalkyl or phenyl substituted with C1 -C3 alkyl or halogen; R2 is hydrogen or C1 -C6 alkyl; and R3 and R4 are the same or different and are hydrogen, C1 -C3 alkyl, C1 -C3 alkoxy or halogen with the provisos that if R2, R3 and R4 are hydrogen, then R1 is not methyl, n-propyl or phenyl substituted with methyl in the ortho or para position; if R1, R2 and R3 are hydrogen then R4 is not hydrogen, methyl or methoxy; and if R1 and R2 are both n-propyl or n-butyl then R3 and R4 are not both hydrogen. These compounds demonstrate utility as hypolipidemic agents. The present invention is also directed to a process for controlling hyperlipidemia in mammals comprising treating mammals with a hyperlipidemia controlling effective amount of a compound having the above-identified structural formula wherein R1 is hydrogen, C1 -C6 alkyl, C2 -C6 carboxyalkyl, C2 -C6 carbalkoxyalkyl, phenyl or phenyl substituted with C1 -C3 alkyl or halogen; R2 is hydrogen or C1 -C6 alkyl; and R3 and R4 are the same or different and are hydrogen, C1 -C3 alkyl, C1 -C3 alkoxy or halogen. Yet another aspect of the present invention is embodied in a pharmaceutical composition comprising a compound having the above structural formula wherein R1 is hydrogen, C1 -C6 alkyl, C2 -C6 carboxyalkyl, C2 -C6 carbalkoxyalkyl, phenyl or phenyl substituted with C1 -C3 alkyl or halogen; R2 is hydrogen or C1 -C6 alkyl; and R3 and R4 are the same or different and are hydrogen, C1 -C3 alkyl, C1 -C3 alkoxy or halogen and a pharmaceutically acceptable carrier therefor.
